Newsletter Subject

Daily Headlines: Barcelona Attack Doesn't Derail ESC Plans

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Aug 19, 2017 12:11 PM

Email Preheader Text

Daily Headlines August 19, 2017 Additional Resources Industry Resources Recent Headlines CME/CE CME/

Daily Headlines August 19, 2017 [Barcelona Attack Doesn't Derail ESC Plans]( [By the Numbers: E-Visits Not Hitting the Mark?]( ['It's All About the Benjamins': What We Heard This Week]( [Key Strategies To Build a New Physician Compensation Model]( [iMedicalApps: Non-Invasive Devices for Heart Disease Screening]( Additional Resources [Diagnosis and Treatment of Relapsed Myeloma]( [AML: Beware of Pre-leukemic Clones Surviving Chemotherapy]( [Support for Omitting ALND in Early Breast Cancer]( Industry Resources [FDA Approved Treatment Option - Non Small Cell Lung Cancer Find A Therapy Option For Previously Treated Advanced NSCLC]( [Renal Cancer Treatment - Official HCP Site A Once-Daily Oral Treatment For Advanced Renal Cell Carcinoma Patients]( [Relapsed Multiple Myeloma - Updated Treatment Option Info Learn About The Head-to-Head Data for this Relapsed MM Treatment Option]( Recent Headlines [High-Calorie Diet Tied to Ca Risk for Some Women]( CME/CE [Inpatient Naloxone Program: Pain Medicine News Report]( [White House Reported to OK August CSR Payment]( [Docs, Hospitals Respond to CMS Retreat on Bundled Payments]( [No Increase in Stroke with Anti-VEGF Tx for Eye Disorders]( CME/CE ADVERTISEMENT This Week's Survey [Does FDA Finally Have the Answer for Smoking?]( [FDA is pushing a]([new anti-smoking strategy](: getting nicotine out of cigarettes because its addictive properties are what keep people smoking CME Spotlights [MDS and Acute Myeloid Leukemia (MDS and AML) @Point of Care]( [Source: @Point of Care]( [Skin Cancers @Point of Care]( [Source: @Point of Care]( [Outcomes in NSCLC: A Focus on Quality Improvement-Part1]( [Source: RMEI Medical Education]( [A Patient-Centric, Performance Measures-Based Approach to NSCLC]( [Source: RMEI Medical Education]( [Treatment of a Relapsing High-Risk Multiple Myeloma Patient]( [Source: Projects In Knowledge, Inc.]( [Hematology CLL @POC]( [Source: @Point of Care]( [Biosimilar vs. Genericu2026 Are they the same? What do you say to your patient?]( [Source: France Foundation]( [Multiple Myeloma (MM) @Point of Care|Grant|App]( [Source: @Point of Care]( [Treatment of Platinum-Resistant Recurrent Ovarian Epithelial Cancer]( [Source: Projects in Knowledge, Inc.]( [Treatment of Recurrent Cervical Squamous Cell Carcinoma]( [Source: Projects In Knowledge, Inc.]( [Role of Immunomodulatory Drug Therapy in a Patient with Refractory Multiple Myeloma]( [Source: Projects In Knowledge, Inc.]( [Newly Diagnosed Metastatic Prostate Cancer Patient]( [Source: Projects In Knowledge, Inc.]( [Relapsing-Remitting Multiple Sclerosis Patient Who Relapses on Current Treatment]( [Source: Projects In Knowledge, Inc.]( [A Multidisciplinary Approach to Management in Basal Cell Carcinoma]( [Source:Postgraduate Institute for Medicine and DKBMed]( [Basal Cell Carcinoma: A Comprehensive Team Approach to Management]( [Source:Postgraduate Institute for Medicine and DKBMed]( [Breast Cancer @POC]( [Source: @Point of Care]( [Evidence-Based Patient-Centered Management in NSCLC]( [Source: Postgraduate Institute for Medicine and DKBMed]( [Approaches to Managing the Complex Patient with NSCLC]( [Source: Postgraduate Institute for Medicine and DKBMed]( More of Today's Stories [Sprout Contamination Limited to Only a Few Growers, FDA Says]( ['First, Do No Harm ... ']( [This Week in Zika: FDA Takes Steps to Improve Test Performance]( [Is a Two-Drug Tx Up to the Task in BRAF V600E-Mutated NSCLC?]( [OA in Hip and Knee, But Not Hand, Increases CV Risk]( CME/CE [Death by a Thousand Tiny Calls]( [New Player in Suicide Prevention: Gun Sellers]( [CMS Changing Medicare Audit Process]( [GBD: 3.2 Million COPD Deaths Worldwide in 2015]( CME/CE [Daily Vaping Linked to Higher Cigarette Quit Rates]( [HF Perceptions Off; No Elevated Stroke Risk with Anti-VEGF Drugs]( [EndoBreak: SUSTAIN 7 Trial Success; PCOS Overdiagnosis?]( [RA Offspring at No Greater Mortality Risk]( [Can a User Be Shamed Out of Opioid Addiction?]( More news from MedPage Today® Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [EverydayHealth] © Copyright 2017 Everyday Health, Inc. All rights reserved. Use of this site constitutes acceptance of the MedPageToday.com [terms of use]( and [privacy policy.]( The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address:{EMAIL} [Manage my e-mail settings]( | [Unsubscribe from "Daily Headlines"](lst=Daily%20Headlines) Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.